Normothermic Liver Preservation Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

July 23, 2024

Study Completion Date

July 23, 2024

Conditions
End Stage Liver DiseaseLiver Diseases
Interventions
DEVICE

OrganOx metra

Following the routine retrieval procedure at the donor hospital the liver will be flushed with cold preservation solution and prepared for cannulation. The donor organ is then placed on the OrganOx metra device and will be perfused with warmed solution. The OrganOx metra device containing the donor organ is then transported to the recipient transplant centre. The donor liver is then removed from the device and flushed with standard of care preservation solution. Alternatively, where more practical, the livers will be transported to the University of Alberta hospital with ≤ 6 hours of cold storage and then placed on the metra™ for ≥ 4 hours. Implantation and reperfusion of the liver proceed as per the usual practice of the recipient transplant centre.

Trial Locations (1)

T6G2C8

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT03089840 - Normothermic Liver Preservation Trial | Biotech Hunter | Biotech Hunter